| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
vascular endothelial growth factor A | 0.266 | 0.923 | 2.4E-05 |
|
disease | 0.400 | None | 0.947 | 4 | 0 | 1997 | 2020 | ||||||||
|
TNF superfamily member 10 | 0.413 | 0.885 | 0.13 |
|
disease | 0.400 | None | 0.969 | 4 | 0 | 2001 | 2019 | ||||||||
|
X-ray repair cross complementing 1 | 0.421 | 0.923 | 6.3E-09 |
|
disease | 0.400 | None | 0.963 | 3 | 0 | 2002 | 2018 | ||||||||
|
alpha-methylacyl-CoA racemase | 0.510 | 0.769 | 2.7E-02 |
|
disease | 0.400 | None | 0.966 | 3 | 0 | 2002 | 2020 | ||||||||
|
interleukin 10 | 0.281 | 0.923 | 5.9E-03 |
|
disease | 0.400 | None | 0.815 | 3 | 0 | 2001 | 2020 | ||||||||
|
signal transducer and activator of transcription 3 | 0.320 | 0.923 | 1.00 |
|
disease | 0.400 | None | 0.989 | 3 | 0 | 2000 | 2019 | ||||||||
|
erb-b2 receptor tyrosine kinase 2 | 0.328 | 0.923 | 6.0E-03 |
|
disease | 0.400 | None | 0.945 | 3 | 0 | 1992 | 2019 | ||||||||
|
cyclin dependent kinase inhibitor 1B | 0.409 | 0.769 | 0.62 |
|
disease | 0.400 | None | 0.875 | 3 | 0 | 1996 | 2019 | ||||||||
|
ETS variant transcription factor 1 | 0.631 | 0.385 | 0.94 |
|
disease | 0.400 | None | 0.962 | 3 | 0 | 2005 | 2020 | ||||||||
|
enhancer of zeste 2 polycomb repressive complex 2 subunit | 0.376 | 0.885 | 1.00 |
|
disease | 0.400 | None | 0.989 | 3 | 0 | 2002 | 2020 | ||||||||
|
MYC proto-oncogene, bHLH transcription factor | 0.344 | 0.923 | 1.00 |
|
disease | 0.400 | None | 0.970 | 3 | 0 | 1998 | 2020 | ||||||||
|
insulin like growth factor binding protein 3 | 0.439 | 0.808 | 0.91 |
|
disease | 0.400 | None | 0.943 | 3 | 0 | 1996 | 2018 | ||||||||
|
insulin like growth factor 1 | 0.318 | 0.885 | 0.27 |
|
disease | 0.400 | None | 0.946 | 3 | 0 | 1993 | 2019 | ||||||||
|
nitric oxide synthase 3 | 0.378 | 0.885 | 6.7E-07 |
|
disease | 0.400 | None | 0.905 | 3 | 0 | 2002 | 2018 | ||||||||
|
epidermal growth factor receptor | 0.295 | 0.885 | 0.37 |
|
disease | 0.400 | None | 0.972 | 3 | 0 | 1994 | 2019 | ||||||||
|
glutathione S-transferase mu 1 | 0.380 | 0.923 | 2.1E-03 |
|
disease | 0.400 | None | 0.887 | 3 | 0 | 1998 | 2019 | ||||||||
|
plasminogen activator, urokinase | 0.425 | 0.923 | 2.3E-06 |
|
disease | 0.400 | None | 1.000 | 3 | 0 | 1995 | 2019 | ||||||||
|
estrogen receptor 1 | 0.324 | 0.962 | 1.00 |
|
disease | 0.400 | None | 0.970 | 2 | 0 | 1996 | 2019 | ||||||||
|
cytochrome P450 family 1 subfamily A member 1 | 0.436 | 0.846 | 1.1E-17 |
|
disease | 0.400 | None | 0.931 | 2 | 0 | 1998 | 2019 | ||||||||
|
tumor protein D52 | 0.597 | 0.692 | 8.5E-05 |
|
disease | 0.400 | None | 1.000 | 2 | 0 | 2004 | 2019 | ||||||||
|
transforming growth factor beta 1 | 0.287 | 0.962 | 3.7E-02 |
|
disease | 0.400 | None | 0.929 | 2 | 0 | 1994 | 2020 | ||||||||
|
AKT serine/threonine kinase 1 | 0.311 | 0.962 | 0.98 |
|
disease | 0.400 | None | 0.992 | 2 | 0 | 2000 | 2019 | ||||||||
|
cyclin dependent kinase inhibitor 1A | 0.403 | 0.769 | 1.9E-03 |
|
disease | 0.400 | None | 0.966 | 2 | 0 | 1995 | 2019 | ||||||||
|
hepsin | 0.641 | 0.577 | 1.00 |
|
disease | 0.400 | None | 0.960 | 2 | 0 | 2001 | 2019 | ||||||||
|
apurinic/apyrimidinic endodeoxyribonuclease 1 | 0.458 | 0.846 | 1.9E-07 |
|
disease | 0.400 | None | 1.000 | 2 | 0 | 2006 | 2019 |